Burjeel’s 11% ADX IPO set AED 10.4bn benchmark for UAE hospitals

Burjeel Holdings listed an 11% stake on the Abu Dhabi Securities Exchange at AED 2.00 a share, valuing the hospital group at AED 10.4 billion on 10 October 2022.

For healthcare CEOs, CFOs and owners, the deal created a quoted reference point for UAE hospital assets at a time when lenders, acquirers and family-owned operators needed cleaner benchmarks for scale, payer mix and specialty capacity.

What Burjeel sold

Burjeel Holdings offered 550,729,221 ordinary shares, equal to 11% of issued share capital, according to company announcements around the IPO. The offer included 200,397,665 new shares and up to 350,331,555 existing shares sold by VPS Healthcare Holdings.

The subscription period opened on 30 September 2022 and closed on 4 October 2022. Trading began on 10 October 2022 under the ticker BURJEEL. Burjeel Holdings said the book was covered 29 times, with gross proceeds of more than AED 1.1 billion.

• Offer size: 550,729,221 shares, or 11% of issued share capital.
• Final price: AED 2.00 per share.
• Market value: about AED 10.4 billion at listing.
• Demand: 29 times covered, according to Burjeel Holdings.

“Listing of an 11% stake on main market of ADX”
— Burjeel Holdings announcement, 26 September 2022

What the valuation means for operators

For CFOs, the AED 10.4 billion valuation set a visible peer marker for hospital groups that depend on insurance reimbursement, high utilisation and physician productivity. Boards can use that benchmark when reviewing debt capacity, minority stake sales or succession-led transactions.

For COOs, the signal is scale. Burjeel Holdings entered the market with brands including Burjeel, Medeor, LLH, Lifecare and Tajmeel, and with operations across Abu Dhabi, Dubai, Sharjah and Oman.

That footprint gives listed healthcare groups more public exposure to quarterly questions on occupancy, outpatient volumes, physician hiring and payer delays. Private operators that compete with Burjeel Holdings should expect investors and banks to ask for cleaner operating dashboards.

What executives should watch next

The IPO followed International Holding Company taking a 15% stake in Burjeel Holdings in September 2022. That gave the transaction a local institutional anchor before retail and professional investors subscribed.

Burjeel Holdings had also signed a non-binding memorandum with Saudi Arabia’s Ministry of Investment on 24 August 2022 to explore investment of up to USD 1 billion in the kingdom by 2030. That shifted the IPO from a UAE liquidity event into a regional growth story.

The practical takeaway for UAE healthcare operators is valuation discipline. Burjeel Holdings created a public comparator for hospital chains seeking capital, selling minority stakes or negotiating bank facilities in 2026.

CEOs should watch whether public investors reward growth through new beds, specialty services or Saudi expansion. CFOs should compare revenue per facility, EBITDA margin and working capital against listed peers where disclosures allow it. COOs should assume that multi-emirate scale carries higher expectations for standardised licensing files, quality metrics and claims controls across DHA, DOH and MOHAP jurisdictions.

The next signal is Burjeel Holdings performance against the expectations implied by its AED 10.4 billion debut value. If margins hold while the group expands, smaller UAE providers will face tougher questions when pitching investors. If margins weaken, buyers will price future healthcare deals with more caution.